Search Results
Results found for "Zhan-Guo Gao"
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
At early stages, breadth matters more than precision. Cast a wide net. Follow anomalies.
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
The GPCR Precision Blueprint is more than a concept.
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
method can’t resolve subtle potency differences, the team prefers to acknowledge that limitation rather than
- The Five Traps of Ignoring Kinetics
That’s your signal: kinetics are moving faster than your tools can measure.
- Curve Shifts Don’t Lie, But Your Eyes Might
against standards and across methods Trust that your conclusions reflect reality, not bias This is more than
- Understanding the Journey: Catherine Demery's Path to Addiction Science
She found herself drawn toward the science behind the drugs, rather than their clinical application.
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why would
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
suggesting that the selectivity of the G-protein lies in intrinsic features of the receptor rather than
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
direction, enabling others to move, and owning tradeoffs with imperfect inputs. 3️⃣ Do you explain more than
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
Premium Members receive exclusive discounted access — making it easier than ever to deepen expertise
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
BBB , and since their targets are on the membrane of cells, they have easier access to the receptors than
- Why Opposing Processes Matter for Your Next GPCR Drug
example, invites reflex bradycardia that blunts its heart rate liability—making it a better inotrope than
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
When a compound’s off-rate is slower than its clearance, its biological effect outlives its plasma presence
- Therapeutic validation of an orphan G protein‐coupled receptor
these ligands are orthosteric agonists such as alkylpyrimidine‐4,6‐diol derivatives (Liu et al., 2016; Zhang
- From Snapshots to Predictions: Why Mechanism of Action Matters
mechanisms with confidence Apply models to design cost-efficient, informative experiments This is more than
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
For drug discovery teams and scientists, staying ahead requires more than just reading papers—it demands
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
that sequence conceals a significant flaw; it treats FDA approval as the final checkpoint , rather than
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
role in disease pathology and highlight allosteric sites that might be more amenable to drug targeting than
- 📰 GPCR Weekly News, July 1 to 7, 2024
Jianming Han, Tao Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology Submit your abstract today; you have less than two weeks!
- Chemokine receptor-targeted drug discovery: progress and challenges
overexpressed and promote cancer progression, and use promiscuous non-peptide antagonists able to target more than
- 📰 GPCR Weekly News, June 17 to 23, 2024
Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic plates more than
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Zhao, P., et al., Activation of the GLP-1 receptor by a non-peptidic agonist.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
directly in living cells produces data that are both more physiologically relevant and more reproducible than
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Z., Wilderman, A., Katakia, T., McCann, T., Yokouchi, H., Zhang, L., Corriden, R., Liu, D., Feigin, M
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
The affinities of these ligands in live cells were higher than in FA assay, but this can be caused by
- Ode to GPCRs
Zhang, X. & Eggert, U. S.



















